- Decision: Reject
- Avg Score: 7.00
- Scores: 5, 8, 8
Now I have a thorough understanding of the paper. Let me write the final consolidated review.

## Summary
This paper proposes Force-guided Bridge Matching (FBM), a generative model for full-atom time-coarsened molecular dynamics of peptides. FBM incorporates an intermediate force field into a bridge matching framework, enabling direct sampling from a Boltzmann-constrained distribution without MCMC resampling steps. The method uses three neural networks (v_θ, u_θ, w_θ) built on TorchMD-NET for SO(3)-equivariant predictions. Experiments on Alanine Dipeptide and a newly curated PepMD dataset show FBM achieves state-of-the-art validity (Val-CA) and competitive distributional similarity.

## Strengths
- **Theoretically grounded force guidance for Boltzmann-constrained sampling without resampling**: Proposition 2 derives the vector field modification v' = v* − (σ²/2)k∇ε_t, and Proposition 3 establishes boundary consistency to the MD force field. This is a principled framework that avoids the MCMC resampling bottleneck of prior methods like Timewarp.
- **Significant validity improvement on PepMD**: Table 2 shows FBM achieves Val-CA of 0.616 vs. 0.115 for Timewarp and 0.367 for FBM-base — a large and practically meaningful improvement in generating physically plausible conformations.
- **Demonstrated transferability to unseen peptides**: The PepMD test set contains 14 peptides with diverse sequences (3–10 residues) not seen during training. FBM maintains top performance across metrics (Table 2), and Figure 3c shows ~10× efficiency gain in ESS/s over MD.
- **Equivariant architecture**: All neural networks use TorchMD-NET, ensuring SO(3)-equivariance in predicted vector fields — essential for physically meaningful atomic displacement predictions.

## Weaknesses

### Fatal
None.

### Major
- **No ablation study isolating the contribution of individual components.** The method comprises: (i) three neural networks (v_θ, u_θ, and w_θ which itself has three sub-networks w^(1), w^(2), w^(3)), (ii) a two-stage training pipeline, (iii) an auxiliary distance loss (L_aux), and (iv) a boundary-force loss (L_bnd). The only controlled comparison is FBM vs. FBM-base, which bundles all additions together. It is therefore unclear how much of the performance gain — especially the large Val-CA improvement (0.616 vs. 0.367) — is attributable to the force guidance itself versus the auxiliary loss, boundary loss, or additional model capacity from the extra networks. This undermines the paper's central claim that the intermediate force field drives the improvement.
- **The core claim of targeting the Boltzmann-constrained distribution is not directly evaluated.** The paper asserts that FBM shifts the generated distribution toward lower-energy (Boltzmann-preferred) regions, but no experiment compares the energy distribution of generated samples (using the MD potential) against the reference MD distribution. The evaluation relies on proxy metrics (JS distances on PWD, RG, TIC, TIC-2D and Val-CA), which are informative but do not directly measure Boltzmann targeting — i.e., whether the reweighting factor exp(−kε(X)) is actually being respected in the generated ensemble.
- **Distributional similarity gains are modest and not assessed for statistical significance.** On PepMD (Table 2), FBM's JS distance improvements over both FBM-base and Timewarp are very small (e.g., PWD: 0.573 vs. 0.576 vs. 0.575; TIC: 0.631 vs. 0.639 vs. 0.633), and the standard deviations across peptides (e.g., PWD: ±0.064, TIC: ±0.077) are large relative to these differences. The paper reports no confidence intervals or significance tests. Since the primary complexity justification for FBM rests partly on these metrics, the evidence here is weak.

### Minor
- **The paper claims Timewarp generates invalid conformations on AD but provides only qualitative visual evidence.** On AD (Table 1), Timewarp outperforms FBM on TIC-2D (0.719 vs. 0.733), and the paper dismisses this by stating it "comes at the cost of generating invalid conformations." However, no Val-CA or analogous numerical validity metric is reported for AD. The supporting Ramachandran plots (Figure 3) provide qualitative evidence, but a quantitative comparison is missing.
- **The large Val-CA gap between FBM (0.616) and Timewarp (0.115) on PepMD lacks diagnostics.** Timewarp is a well-established method on small peptides, so its extremely low validity here warrants explanation. The paper does not report diagnostics such as Timewarp's acceptance rate, chain-length effects, or per-peptide validity breakdown that would clarify whether the comparison is operating in a regime disadvantageous to Timewarp.
- **Key hyperparameters are not reported.** The values of λ_aux (balancing the auxiliary loss), σ (the Brownian bridge diffusion coefficient), the mini-batch size B, and the number of discretization steps during inference are not given. This makes it difficult to reproduce or assess the sensitivity of results to these choices.
- **The modeling assumption p_t(X_t|X_0,X_1) = q_t(X_t|X_0,X_1) is stated without justification or sensitivity analysis.** This assumption (Section 3.3, after Equation 6) implies that the Boltzmann correction factorizes entirely over the endpoints, leaving the path distribution unmodified. This is a non-trivial claim about how the Boltzmann constraint propagates through time, and its potential impact on the dynamics is not discussed or tested.
- **ESS/s results are shown only as multiples of MD's median (Figure 3c).** Absolute ESS values and a direct efficiency comparison against Timewarp (which also uses MCMC) would be more informative. The efficiency comparison is only against MD.

### Trivial
- The reference to Section \ref{sec:arch} for architecture details appears to point to an appendix section not present in the extracted text.

## Nice-to-Haves
- Code and data release (especially the PepMD dataset) would benefit reproducibility.
- Reporting per-peptide results in a table rather than only mean/std across peptides would help identify whether FBM's advantage is consistent or driven by a few peptides.
- A direct comparison of the learned intermediate force field w_θ against the true MD force at t=0 and t=1 (as guaranteed by Proposition 3) would provide a valuable sanity check.
- Wall-clock training and inference times compared to baselines would contextualize the computational overhead.

## Removed Points
These points are flagged to be removed; treat them with caution.

- **"Timewarp may not have been properly tuned"** (Harsh Critic, Critical Issues #1): This is speculative. The paper states all baselines were "trained from scratch for fair comparison," and without evidence of mistuning, this is not a verifiable weakness.
- **"ITO and Score Dynamics perform very poorly, suggesting improper tuning"** (Harsh Critic): Similarly speculative. The paper notes these methods may be designed for different resolutions/settings, so their poor performance may be expected.
- **"Mini-batch force field estimates may be inaccurate with typical batch sizes"** (Harsh Critic, Critical Issues #3): This is a hypothetical concern without evidence that the actual batch size is insufficient. The paper cites a contrastive learning reference for this estimation approach.
- **"Figure 2 contours are estimated from kernel densities, masking sampling biases"** (Harsh Critic): Kernel density estimation is standard practice for plotting distributions from discrete samples; this is not a methodological flaw.
- **"Code and data not available"** (Harsh Critic, Missing Parts & Places to Improve): The hard rules specify that criticisms about availability of cited entities should be removed. While this is a practical concern, it is standard for conference submissions to not include code at submission time.
- **Strength Finder's generic strengths about "addressing an important problem"**: Removed as generic/superficial. The retained strengths are specifically grounded in paper content.

## Novel Insights
None beyond the paper's own contributions. The reviews surface legitimate concerns about experimental validation depth but do not provide a fundamentally new lens on the work that the authors themselves have not considered (the limitations section honestly acknowledges several of these issues).

## Suggestions
1. **Add an ablation study isolating the intermediate force field**: Compare FBM-base against FBM-base + force guidance only (without L_aux and L_bnd) to measure the standalone contribution of ∇ε_t. Also ablate L_aux and L_bnd individually.
2. **Directly evaluate Boltzmann targeting**: Compute the potential energy distribution of generated samples using the MD force field and compare it to the reference MD distribution and the FBM-base distribution. A clear shift toward lower energies would directly validate the core claim.
3. **Report statistical significance**: Add confidence intervals or bootstrap-based significance tests for the key metrics, especially where differences are small relative to standard deviations.
4. **Provide diagnostics for the Timewarp validity gap**: Report Timewarp's MCMC acceptance rates on PepMD and per-peptide validity to clarify whether the comparison is fair.
5. **Report all key hyperparameters**: λ_aux, σ, batch size B, inference discretization steps, and training details (learning rate, number of training steps for each stage).
